Genmab — Oktober 2020
-
The fair value of each restricted stock unit is equal to the closing market price on the date of grant of one Genmab A/S share, DKK 2,317.
The restricted stock units will vest on the first banking day of the month following a period of three years from the date of grant. Furthermore, the restricted stock units are subject to vesting conditions set out in the restricted stock unit program adopted by the board of directors in accordance with the Remuneration Policy adopted by the shareholders...
-
t the annual general meeting. Information concerning Genmabs restricted stock unit program can be found on www.genmab.com under Investors Stock information Restricted stock units.
The exercise price for each warrant is DKK 2,317. Each warrant is awarded cost-free and entitles the owner to subscribe one share of nominally DKK 1 subject to payment of the exercise price. By application of the Black-Scholes formula, the fair value of each warrant can be calculated as DKK 748.02.
-
The warrants vest three years after the grant date, and all warrants expire at the seventh anniversary of the grant date. The new warrants have been granted on the terms and conditions set out in the warrant program adopted by the board of directors on March 28, 2017. Information concerning Genmabs warrant schemes can be found on www.genmab.com under Investors Stock information Warrants.
-
Pharma og biotek vender snuden op igen efter to dage med fald. De aktier som er faldet mest stiger umiddelbart også mest.
-
Lidt underligt at DK således har kørt modsat af NBI de seneste to dage.
-
9.29: "Dansk pharma- og biotek".
-
9.29 er chatindlæg 9.29.
-
Nu vender de danske i samlet flok snuden nedad.
-
Pudsigt at se at de kører sådan i takt over en bred kam.
-
Det er den samme "fuksvanse-algo" som er sat på.
-
Den elskede fukssvans:)
-
Hvornår er det vi kan forvente salgstal for sept?
-
For biotektosser: https://www.proinvestor.com/boards/87389/For-biotektosser
-
Stoxx: Europæiske health care-aktier på kanten af teknisk nedbrud: https://www.proinvestor.com/investornyt/668366/stoxx-europaeiske-health-care-aktier-pa-kanten-af-teknisk-nedbrud
-
Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism https://mct.aacrjournals.org/content/19/10/2126
-
Facebook kommentar: After 51 infusions, yesterday was my first sub-q dara. The only pain was the belly pinch to get the injection. It lasted about 3m 15s, and was much easier than getting an IV. Without the infusion, I’m back to getting oral dex, so my voice is much raspier than it was with the infused dex.
-
Subcutan dara tager nok helt over.
-
https://borsen.dk/nyheder/finans/c25-bosser-har-formue-placeret-i-egne-selskaber JW topper C25 med formue på 1,5 mia ddk i Genmab. Artiklen I Børsen omtaler at “De her mennesker er spydspidser for selskaber, der skaber gigantiske værdier til ejerne”
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind